CIK 0001618835 · Non-accelerated filer<br>Smaller reporting company
Evofem Biosciences, Inc.
Sign in to watch- Ticker
- EVFM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208527075
- Phone
- (858) 550-1900
- Business address
- 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
- Former names
- Neothetics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-07-31 | File Justin J. Chief Financial Officer | Grant or award · Stock option (right to buy) | +0 | 114,000 | ||
| 2018-07-31 | Barrans Russell Chief Commercial Officer | Grant or award · Stock option (right to buy) | +98,800 | 98,800 | ||
| 2018-07-31 | Fitzpatrick Alexander A General Counsel and Secretary | Grant or award · Stock option (right to buy) | +0 | 104,500 | ||
| 2018-07-31 | Lynch Thomas G Director | Grant or award · Stock option (right to buy) | +0 | 85,500 | ||
| 2018-07-31 | PELLETIER SAUNDRA L Chief Executive Officer | Grant or award · Stock option (right to buy) | +0 | 313,500 | ||
| 2018-07-31 | Culwell Kelly Chief Medical Officer | Grant or award · Common Stock | +98,800 | 98,800 | ||
| 2018-07-24 | O'Brien Anthony Stephen Director | Grant or award · Common Stock | +12,875 | 12,875 | ||
| 2018-07-02 | Barrans Russell Chief Commercial Officer | Grant or award | +11,666 | 11,666 | ||
| 2018-07-02 | Barrans Russell Chief Commercial Officer | Shares withheld for taxes | −2,840 | $2.46 | $7K | 8,826 |
| 2018-07-02 | File Justin J. Chief Financial Officer | Grant or award | +300,000 | 300,000 | ||
| 2018-07-02 | File Justin J. Chief Financial Officer | Shares withheld for taxes | −119,510 | $2.46 | $294K | 180,490 |
| 2018-07-02 | PELLETIER SAUNDRA L Chief Executive Officer | Grant or award | +825,000 | 825,000 | ||
| 2018-07-02 | PELLETIER SAUNDRA L Chief Executive Officer | Shares withheld for taxes | −493,187 | $2.46 | $1.2M | 331,813 |
| 2018-07-02 | Fitzpatrick Alexander A General Counsel and Secretary | Grant or award | +70,000 | 70,000 | ||
| 2018-07-02 | Lynch Thomas G Director | Option exercise | +75,000 | 75,000 | ||
| 2018-07-02 | Lynch Thomas G Director | Grant or award · Restricted Stock Units | +75,000 | 75,000 | ||
| 2018-07-02 | Lynch Thomas G Director | Option exercise · Restricted Stock Units | −75,000 | 0 | ||
| 2018-07-02 | Culwell Kelly Chief Medical Officer | Grant or award | +13,733 | 13,733 | ||
| 2018-07-02 | Culwell Kelly Chief Medical Officer | Shares withheld for taxes | −4,748 | $2.46 | $12K | 8,985 |
| 2018-05-22 | Invesco Ltd. 10% owner | Purchase | +2,127,659 | $4.69 | $10.0M | 9,165,157 |
Page 11 of 20 · 383 trades